Dr. Goy on the Combination of Biological Therapies in Relapsed MCL
August 3rd 2018Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the combination of biological therapies in the treatment of patients with relapsed mantle cell lymphoma (MCL).
Read More